Inventor · disambiguated record
Daniel Scheps
Also filed as: SCHEPS DANIEL
5 granted patents·4 pending applications·4 citations·filing 2016–2021
68Inventor score
Top patents by PatentIndex Score
9 records- 0183US10603353B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Mar 31, 2020·2 cites·27 claims
- 0275US11357821B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2019·Granted Jun 14, 2022·1 cites·23 claims
- 0370US11078472B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Aug 3, 2021·1 cites·17 claims
- 0461US2022010294A1Novel recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2021·Application pending·0 cites
- 0554US11155802B2Recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Oct 26, 2021·0 cites·13 claims
- 0650US2023346949A1A method of forming a conjugate of a sulfonamide and a polypeptideSANOFI SA·Filed 2020·Application pending·0 cites
- 0742US2021008156A1Novel recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Application pending·0 cites
- 0841US11952601B2Recombinant botulinum toxin with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Apr 9, 2024·0 cites·16 claims
- 0939US2020354706A1Novel recombinant botulinum toxin with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Scheps files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →